Broad Institute is a nonprofit biomedical research center dedicated to improving human health by understanding the roots of disease and turning scientific insights into benefits for patients. Its multidisciplinary community brings together researchers working across genetics, biology, artificial intelligence, and therapeutic development. Broad’s research spans conditions including cancer, brain and cardiovascular diseases, diabetes, infectious diseases, kidney disease, obesity, and rare disorders, as well as fundamental areas such as immunology, metabolism, and genome regulation.

The institute develops and scales technology platforms that support scientific discovery, including capabilities in genomics, data science, drug discovery, imaging, proteomics, and metabolomics. It also makes scientific resources available to researchers, including datasets, computational tools, and publications. Through collaborations, consortia, technology licensing, and partnerships with pharmaceutical, biotechnology, and technology companies, Broad works to extend the impact of its discoveries. Patient-partnered research is another part of its approach.

Broad also supports education and public engagement through free learning resources, student research opportunities, public programs, and the Broad Discovery Center, a free educational space focused on research into human disease.